Cantor Raises Lucid Price Target to $26 After Investor Meetings

Analyst: Andres Sheppard 1 min read Reproduced verbatim
Rating
Neutral
Target
$26
from $20 (+30%)
Outcome
Missed
within 12 months
Cantor and Lucid logos

What the analyst said

Cantor Fitzgerald analyst Andres Sheppard raised the price target on Lucid Group Inc.

(NASDAQ: LCID) to $26.00 (from $20.00) while maintaining a Neutral rating.

“Last week, we hosted investors for meetings with Marc Winterhoff, interim CEO of Lucid, and Taoufiq Boussaid, CFO, in NYC.

Key topics of conversation included the recent robotaxi partnership with Uber/Nuro, vehicle deliveries expectations, ramp-up of the Lucid Gravity SUV, upcoming launch of the midsize platform, the company’s recent reverse stock split, the relationships with the Government of Saudi Arabia & the PIF, and its pending capital needs.

We continue to believe the launch of the midsize platform (2H26E) will be a material catalyst that should help the company scale and improve margins further. We Increased our PT to $26 (from $20).”

“In FY24, LCID produced/delivered 9,029/10,241 vehicles, respectively, and so far in 1H25, Lucid has produced/delivered 6,075/6,418 vehicles, respectively.

The company is guiding to produce 18,000-20,000 vehicles in FY25, and for 3Q25, we are expecting LCID to deliver 4,745 vehicles (vs.

Visible Alpha Consensus of 4,286), and for LCID to produce 5,550 vehicles vs. Visible Alpha Consensus of 5,175 vehicles. For FY25, we are modeling deliveries/production of 16,650/18,500 vehicles, vs.

Visible Alpha consensus of 15,669/17,800 vehicles, respectively.”

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

LCID trades at $3.29. The 5 analysts who set a target in the last 3 months range from $3 to $11, with a median of $6. This $26 target is 333% above the median, the highest on the Street.

Since the note LCID has moved −86% (from $23.96). The 12-month window closed on September 29, 2026.

Track record

This call✗ Not reached within 12 months: a year after the note LCID closed at $4.15, 84% below the $26 target, and it moved the other way. Same target as this firm’s September 24, 2025 note, so it is scored there.

Firm track recordCantor: 79% of its 56 targets at least a year old were reached within 12 months (#15 of 26 firms); on Lucid, 4 of 6. Accuracy ranking →

Cantor on Lucid

Cantor price targets on Lucid

8 calls from August 4, 2025 to November 6, 2025. The target went from $30 to $21 (−30%). The rating stayed Hold.

Cantor targetLCID share price
  1. November 6, 2025Target cut from $26 (−19%)Hold$21
  2. October 6, 2025Kept the $26 targetHold$26
  3. September 29, 2025 This noteKept the $26 targetHold$26
  4. September 24, 2025Target raised from $20 (+30%)Hold$26
  5. September 8, 2025Kept the $20 targetHold$20
  6. September 5, 2025Target cut from $30 (−33%)Hold$20
  7. August 6, 2025Kept the $30 targetHold$30
  8. August 4, 2025Earliest call shownHold$30

Targets are adjusted for the 1-for-10 reverse split on Sep 2, 2025, so every call is in the same share terms as this note.

Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.